Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 210

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

Open access
Roura, Esther, Travier, Noémie, Waterboer, Tim, de Sanjosé, Silvia, Bosch, F. Xavier, Pawlita, Michael, Pala, Valeria, Weiderpass, Elisabete, Margall, Núria, Dillner, Joakim, Gram, Inger T., Tjønneland, Anne, Munk, Christian, Palli, Domenico, Khaw, Kay-Tee, Overvad, Kim, Clavel-Chapelon, Françoise, Mesrine, Sylvie, Fournier, Agnès, Fortner, Renée T., Ose, Jennifer, Steffen, Annika, Trichopoulou, Antonia, Lagiou, Pagona, Orfanos, Philippos, Masala, Giovanna, Tumino, Rosario, Sacerdote, Carlotta, Polidoro, Silvia, Mattiello, Amalia, Lund, Eiliv, Peeters, Petra H., Bueno-de-Mesquita, H. B(as)., Quirós, J. Ramón, Sánchez, María-José, Navarro, Carmen, Barricarte, Aurelio, Larrañaga, Nerea, Ekström, Johanna, Lindquist, David, Idahl, Annika, Travis, Ruth C., Merritt, Melissa A., Gunter, Marc J., Rinaldi, Sabina, Tommasino, Massimo, Franceschi, Silvia, Riboli, Elio, Castellsagué, Xavier · 2016 · PLOS ONE

Abstract

BACKGROUND: In addition to HPV, high parity and hormonal contraceptives have been associated with cervical cancer (CC). However, most of the evidence comes from retrospective case-control studies. The aim of this study is to prospectively evaluate associations between hormonal factors and risk of developing cervical intraepithelial neoplasia grade 3 (CIN3)/carcinoma in situ (CIS) and invasive cervical cancer (ICC). METHODS AND FINDINGS: We followed a cohort of 308,036 women recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. At enrollment, participants completed a questionnaire and provided serum. After a 9-year median follow-up, 261 ICC and 804 CIN3/CIS cases were reported. In a nested case-control study, the sera from 609 cases and 1,218 matched controls were tested for L1 antibodies against HPV types 11,16,18,31,33,35,45,52,58, and antibodies against Chlamydia trachomatis and Human herpesvirus 2. Multivariate analyses were performed to estimate hazard ratios (HR), odds ratios (OR) and corresponding 95% confidence intervals (CI). The cohort analysis showed that number of full-term pregnancies was positively associated with CIN3/CIS risk (p-trend = 0.03). Duration of oral contraceptives use was associated with a significantly increased risk of both CIN3/CIS and ICC (HR = 1.6 and HR = 1.8 respectively for ≥ 15 years versus never use). Ever use of menopausal hormone therapy was associated with a reduced risk of ICC (HR = 0.5, 95%CI: 0.4-0.8). A non-significant reduced risk of ICC with ever use of intrauterine devices (IUD) was found in the nested case-control analysis (OR = 0.6). Analyses restricted to all cases and HPV seropositive controls yielded similar results, revealing a significant inverse association with IUD for combined CIN3/CIS and ICC (OR = 0.7). CONCLUSIONS: Even though HPV is the necessary cause of CC, our results suggest that several hormonal factors are risk factors for cervical carcinogenesis. Adherence to current cervical cancer screening guidelines should minimize the increased risk of CC associated with these hormonal risk factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0147029

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 37

  1. JG Baseman, 2005, The epidemiology of human papillomavirus infections, J Clin Virol, 32, S16, 10.1016/j.jcv.2004.12.008 · DOI · Paper page
  2. V Cogliano, 2005, WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses, Lancet Oncol, 6, 204, 10.1016/S1470-2045(05)70086-3 · DOI · Paper page
  3. 2007, Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy, IARC Monogr Eval Carcinog Risks Hum, 91, 1
  4. P Appleby, 2007, Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies, Lancet, 370, 1609, 10.1016/S0140-6736(07)61684-5 · DOI · Paper page
  5. 2006, Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies, Int J Cancer, 119, 1108, 10.1002/ijc.21953 · DOI · Paper page
  6. S Rinaldi, 2011, Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study, Cancer Epidemiol Biomarkers Prev, 20, 2532, 10.1158/1055-9965.EPI-11-0753 · DOI
  7. E Roura, 2014, Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort, Int J Cancer, 135, 453, 10.1002/ijc.28666 · DOI · Paper page
  8. X Castellsague, 2014, Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort, Int J Cancer, 135, 440, 10.1002/ijc.28665 · DOI
  9. T Waterboer, 2005, Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins, Clin Chem, 51, 1845, 10.1373/clinchem.2005.052381 · DOI · Paper page
  10. P Sehr, 2002, HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase, J Virol Methods, 106, 61, 10.1016/S0166-0934(02)00134-9 · DOI
  11. GM Clifford, 2007, Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea, Cancer Epidemiol Biomarkers Prev, 16, 1874, 10.1158/1055-9965.EPI-07-0349 · DOI
  12. T Peters, 2012, Validity of a short questionnaire to assess physical activity in 10 European countries, Eur J Epidemiol, 27, 15, 10.1007/s10654-011-9625-y · DOI · Paper page
  13. V Moreno, 2002, Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study, Lancet, 359, 1085, 10.1016/S0140-6736(02)08150-3 · DOI · Paper page
  14. PE Castle, 2002, A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women, J Natl Cancer Inst, 94, 1406, 10.1093/jnci/94.18.1406 · DOI · Paper page
  15. PE Castle, 2005, Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology, Int J Cancer, 117, 1007, 10.1002/ijc.21279 · DOI
  16. KE Jensen, 2013, Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up, Br J Cancer, 108, 234, 10.1038/bjc.2012.513 · DOI
  17. JR Daling, 1996, The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection, Cancer Epidemiol Biomarkers Prev, 5, 541
  18. A Berrington, 2002, Oral contraceptives and cervical cancer, Lancet, 360, 410, 10.1016/S0140-6736(02)09578-8 · doi:10.1016/s0140-6736(02)09578-8
  19. TS Shields, 2004, A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus, Cancer Epidemiol Biomarkers Prev, 13, 1574, 10.1158/1055-9965.1574.13.10 · DOI
  20. K Syrjanen, 2006, Oral contraceptives are not an independent risk factor for cervical intraepithelial neoplasia or high-risk human papillomavirus infections, Anticancer Res, 26, 4729
  21. M Moodley, 2003, The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review, Int J Gynecol Cancer, 13, 103, 10.1046/j.1525-1438.2003.13030.x · DOI
  22. A Gadducci, 2011, Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature, Gynecol Endocrinol, 27, 597, 10.3109/09513590.2011.558953 · DOI · Paper page
  23. SH Chung, 2010, Estrogen and ERalpha: culprits in cervical cancer?, Trends Endocrinol Metab, 21, 504, 10.1016/j.tem.2010.03.005 · DOI · Paper page
  24. YA Yoo, 2013, Progesterone signaling inhibits cervical carcinogenesis in mice, Am J Pathol, 183, 1679, 10.1016/j.ajpath.2013.07.026 · DOI
  25. N Munoz, 2002, Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study, Lancet, 359, 1093, 10.1016/S0140-6736(02)08151-5 · DOI · Paper page
  26. JV Lacey Jr., 2000, Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix, Gynecol Oncol, 77, 149, 10.1006/gyno.2000.5731 · DOI
  27. HO Adami, 1989, Risk of cancer in women receiving hormone replacement therapy, Int J Cancer, 44, 833, 10.1002/ijc.2910440515 · DOI · Paper page
  28. F Parazzini, 1997, Case-control study of oestrogen replacement therapy and risk of cervical cancer, BMJ, 315, 85, 10.1136/bmj.315.7100.85 · DOI
  29. C Schneider, 2009, Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations, Climacteric, 12, 514, 10.3109/13697130903075352 · DOI
  30. F Parazzini, 1989, Reproductive factors and the risk of invasive and intraepithelial cervical neoplasia, Br J Cancer, 59, 805, 10.1038/bjc.1989.168 · doi:10.1038/bjc.1989.168
  31. C La Vecchia, 1993, Long-term impact of reproductive factors on cancer risk, Int J Cancer, 53, 215, 10.1002/ijc.2910530207 · DOI
  32. JM Deacon, 2000, Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort, Br J Cancer, 83, 1565, 10.1054/bjoc.2000.1523 · DOI · Paper page
  33. KT Zondervan, 1996, Oral contraceptives and cervical cancer—further findings from the Oxford Family Planning Association contraceptive study, Br J Cancer, 73, 1291, 10.1038/bjc.1996.247 · doi:10.1038/bjc.1996.247
  34. E Russo, 2011, Vaginal delivery and low immunity are strongly associated with high-grade cervical intraepithelial neoplasia in a high-risk population, J Low Genit Tract Dis, 15, 195, 10.1097/LGT.0b013e31820918ea · doi:10.1097/lgt.0b013e31820918ea
  35. X Castellsague, 2011, Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies, Lancet Oncol, 12, 1023, 10.1016/S1470-2045(11)70223-6 · DOI
  36. 2007, Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies, Int J Cancer, 120, 885, 10.1002/ijc.22357 · DOI · Paper page
  37. X Castellsague, 2006, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention, J Natl Cancer Inst, 98, 303, 10.1093/jnci/djj067 · DOI · Paper page

Cited by

See all 210

Metadata

Authors
Roura, E., Travier, N., Waterboer, T., de Sanjosé, S., Bosch, F. X., Pawlita, M., Pala, V., Weiderpass, E., Margall, N., Dillner, J., Gram, I. T., Tjønneland, A., Munk, C., Palli, D., Khaw, K.-T., Overvad, K., Clavel-Chapelon, F., Mesrine, S., Fournier, A., Fortner, R. T., Ose, J., Steffen, A., Trichopoulou, A., Lagiou, P., Orfanos, P., Masala, G., Tumino, R., Sacerdote, C., Polidoro, S., Mattiello, A., Lund, E., Peeters, P. H., Bueno-de-Mesquita, H. B., Quirós, J. R., Sánchez, M.-J., Navarro, C., Barricarte, A., Larrañaga, N., Ekström, J., Lindquist, D., Idahl, A., Travis, R. C., Merritt, M. A., Gunter, M. J., Rinaldi, S., Tommasino, M., Franceschi, S., Riboli, E., & Castellsagué, X.
Venue
PLOS ONE
Published
2016-01-25
Volume
11
Issue
1
Pages
e0147029
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2272590651
Cited by
210
References
4
FWCI
15.54
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. https://app.cochat.ai/papers/10.1371/journal.pone.0147029
The paper
Roura, E., Travier, N., Waterboer, T., de Sanjosé, S., Bosch, F. X., Pawlita, M., Pala, V., Weiderpass, E., Margall, N., Dillner, J., Gram, I. T., Tjønneland, A., Munk, C., Palli, D., Khaw, K.-T., Overvad, K., Clavel-Chapelon, F., Mesrine, S., Fournier, A., . . . Castellsagué, X. (2016). The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLOS ONE. https://doi.org/10.1371/journal.pone.0147029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.